Related Experiment Video
Updated: Apr 2, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[Low-dose screening for bronchopulmonary cancer: A general practitioner's perspective]
Elodie Poupin1, Yohann Hays2, Gael Freche3
1Département de médecine générale, université de Poitiers, 6, rue de la Milétrie, 86073 Poitiers, France; Pôle de recherche en soins primaires, université de Poitiers, 6, rue de la Milétrie, 86073 Poitiers, France.
General practitioners (GPs) play a crucial role in lung cancer screening programs. International experiences show GPs are vital for patient selection and follow-up, informing France
Area of Science:
- Oncology
- Public Health
- General Practice
Background:
- Lung cancer poses a significant public health challenge due to high mortality, often linked to delayed diagnosis.
- Low-dose thoracic CT screening has proven effective in reducing lung cancer mortality in major international studies.
- This study investigates the potential integration of lung cancer screening into primary care in France.
Purpose of the Study:
- To explore the application and feasibility of low-dose thoracic CT screening for lung cancer.
- To examine the role of general practitioners (GPs) in implementing lung cancer screening programs.
- To learn from international experiences to inform potential national screening strategies in France.
Main Methods:
- A systematic review of international literature on lung cancer screening programs was conducted.
- Analysis focused on the involvement of general practitioners in patient identification, referral, and follow-up.
- Consideration was given to varying eligibility criteria, integrated smoking cessation strategies, and organizational challenges.
Main Results:
- Several countries (USA, South Korea, Croatia, Poland, Czech Republic) have national lung cancer screening programs involving GPs.
- GPs are essential for patient selection based on risk scores and for post-screening follow-up.
- Key challenges include cost, false positive management, and patient psychological support, alongside the importance of smoking cessation.
Conclusions:
- France is currently in a pilot phase for lung cancer screening, with programs like IMPULSION assessing feasibility.
- Successful implementation requires coordinated efforts from GPs, health authorities, and stakeholders.
- Lessons from international programs are crucial for guiding the development of a national screening strategy in France.
Related Concept Videos
Drug Dosing: Infants and Children
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
